Studies in glioblastoma and leukemia have established a correlation between TfR2 expression and tumor grade, but TfR2 overexpression also increased sensitivity to chemotherapy and, thus, is associated to favorable prognosis [169,171]. This evidence concerns the gene TFR2 and neoplasm.